4-Year Clinical Outcomes and Predictors of Repeat Revascularization in Patients Treated With New-Generation Drug-Eluting Stents-Reference-Cited by-同舟云学术

4-Year Clinical Outcomes and Predictors of Repeat Revascularization in Patients Treated With New-Generation Drug-Eluting Stents

Published:2014-04 Issue:16 Volume:63 Page:1617-1625
ISSN:0735-1097
Container-title:Journal of the American College of Cardiology
language:en
Short-container-title:Journal of the American College of Cardiology

Author:

Taniwaki Masanori,Stefanini Giulio G.,Silber Sigmund,Richardt Gert,Vranckx Pascal,Serruys Patrick W.,Buszman Pawel E.,Kelbaek Henning,Windecker Stephan

Funder

Medtronic Inc

Abbott Vascular, Boston Scientific, and Medtronic

Abbott Vascular, Biotronik, Boston Scientific, Biosensors, Cordis, Medtronic, St. Jude Medical, and Edwards Lifesciences

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference16 articles.

1. Drug-eluting coronary-artery stents;Stefanini;N Engl J Med,2013

2. Unrestricted randomised use of two new generation drug-eluting coronary stents: 2-year patient-related versus stent-related outcomes from the RESOLUTE All Comers trial;Silber;Lancet,2011

3. Clinical Outcome Following Stringent Discontinuation of Dual Antiplatelet Therapy After 12 Months in Real-World Patients Treated With Second-Generation Zotarolimus-Eluting Resolute and Everolimus-Eluting Xience V Stents

4. Comparison of zotarolimus-eluting and everolimus-eluting coronary stents;Serruys;N Engl J Med,2010

5. Myocardial infarction adjudication in contemporary all-comer stent trials: balancing sensitivity and specificity. Addendum to the historical MI definitions used in stent studies;Vranckx;EuroIntervention,2010

Cited by 148 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Temporal Trends in the Outcomes of Percutaneous Coronary Intervention With Zotarolimus Eluting Stents Versus Everolimus Eluting Stents: A Meta‐Analysis of Randomized Controlled Trials;Clinical Cardiology;2024-06

2. Impact of diabetes mellitus on clinical outcomes after first episode in-stent restenosis PCI: Results from a large registry;International Journal of Cardiology;2024-04

3. Identifying Risk Factors for Native Coronary Atherosclerosis Progression After Percutaneous Coronary Intervention;Cardiovascular Innovations and Applications;2024

4. Clinically Driven Revascularization in High-Risk Patients Treated With Ticagrelor Monotherapy After PCI: Insights from the Randomized TWILIGHT Trial;The American Journal of Cardiology;2023-12

5. Development and validation of a nomogram to predict the five-year risk of revascularization for non-culprit lesion progression in STEMI patients after primary PCI;Frontiers in Cardiovascular Medicine;2023-11-29